Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01277640 · ClinicalTrials.gov registry record · Phase 1
Male Tolerance Study of Dapivirine Gel Following Multiple Topical Penile Exposures
A Phase 1 study, sponsored by International Partnership for Microbicides.
- Completed
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
NCT01277640 is a Phase 1 study that has completed, run by International Partnership for Microbicides. The registered enrollment target is 48 participants.
The verdict
NCT01277640, a Phase 1 study, has completed, sponsored by International Partnership for Microbicides.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety of male genitalia when exposed to dapivirine gel following seven once daily applications.
Interventions
- DRUG matched placebo
- DRUG dapivirine
- DRUG universal placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2011-03 |
| Est. Completion | 2011-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01277640
The ClinicalTrials.gov registry entry for NCT01277640 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is International Partnership for Microbicides, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which matched placebo is the first listed.
NCT01277640 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01277640 about?
NCT01277640 is a clinical study titled "Male Tolerance Study of Dapivirine Gel Following Multiple Topical Penile Exposures". The purpose of this study is to determine the safety of male genitalia when exposed to dapivirine gel following seven once daily applications.
What is the current status of trial NCT01277640?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2011-03. Estimated completion is 2011-07.
What interventions are being tested in trial NCT01277640?
The interventions under investigation include: matched placebo (DRUG), dapivirine (DRUG), universal placebo (DRUG).
Who is sponsoring clinical trial NCT01277640?
This trial is sponsored by International Partnership for Microbicides, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.